gms | German Medical Science

83. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

16.05. - 20.05.2012, Mainz

Artikel

Artikel empfehlen

Development and Validation of the Frankfurt Dysphagia Screening (FraDySc) for Patients with head and neck cancer after tumor resection First results

Meeting Abstract

Suche in Medline nach

  • corresponding author Christiane Hey - Univ. HNO-Klinik, Frankfurt/M., Germany
  • presenting/speaker Benjamin Lange - Biologische Fakultät inkl. Psychologie, Göttingen, Germany
  • presenting/speaker Silvia Eberle - Univ. HNO-Klinik, Frankfurt/M., Germany
  • presenting/speaker Timo Stöver - Univ. HNO-Klinik, Frankfurt/M., Germany

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. 83rd Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. Mainz, 16.-20.05.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12hno18

doi: 10.3205/12hno18, urn:nbn:de:0183-12hno185

Veröffentlicht: 23. Juli 2012

© 2012 Hey et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.

Gliederung

Text

Background: Dysphagia is a frequent implication of head and neck cancer (HNC) patients. To date, there is no sufficient screening for swallowing disorders of those patients. Aim of this study is the development and validation of a screening to detect therapy relevant dysphagia of HNC patients after tumor resection.

Methods: The dysphagia screening FraDySc consists of an oromotor testing with a defined water swallow test. FraDySc independently, is tested twice by two therapists followed by a fiberoptic endoscopig evaluation of swallowing (FEES) Langmore-Standard. Since November 2010, 33 HNC patients (Stage II - IV) after tumor resection were documented. Exclusion criteria were a preknown swallowing disorder or neurological diseases. So far, the interraterreliability and the accordance of the Pass/Fail results of FraDySc and FEES were determined.

Results: Up to date the interraterreliability regarding the FraDySc is optimal (Cohen’s κ = 1.00, p < .001) and the concordance of FraDySc and FEES excellent. (Cronbach’s κ = .949).

Conclusion: The first results of this study promise FraDySc as a very good tool for a valid and time efficient identification of patients with a therapy relevant swallowing disorder and therefor the need for an early rehabilitation after tumor resection.